John Cerio

Human Resources Officer presso ORCHARD THERAPEUTICS PLC

Health Technology

Consumer Services

Profilo

John Cerio is currently the Chief Human Resource Officer at Orchard Therapeutics Plc.
Previously, he worked as the Director-Human Resources Corporate Staff at Bristol Myers Squibb Co. He also served as the Vice President-Human Resources at Agenus, Inc. from 2003 to 2011.
Additionally, he held the position of Global Vice President-Human Resources at PerkinElmer Life Sciences, Inc. Mr. Cerio holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.

Posizioni attive di John Cerio

Società	Posizione	Inizio
ORCHARD THERAPEUTICS PLC	Human Resources Officer	-

Tutte le posizioni attive di John Cerio

Precedenti posizioni note di John Cerio

Società	Posizione	Fine
PerkinElmer Life Sciences, Inc. PerkinElmer Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology PerkinElmer Life Sciences, Inc. Provided drug discovery, life science research and clinical screening services. It was headquartered in Boston, MA.	Human Resources Officer	-
BRISTOL-MYERS SQUIBB COMPANY	Human Resources Officer	-
AGENUS INC.	Chief Administrative Officer	-

Vedi nel dettaglio l'esperienza di John Cerio

Formazione di John Cerio

The Trustees of Columbia University in The City of New York	Graduate Degree
Cornell University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John Cerio

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
AGENUS INC.	Health Technology

Aziende private	2
PerkinElmer Life Sciences, Inc. PerkinElmer Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology PerkinElmer Life Sciences, Inc. Provided drug discovery, life science research and clinical screening services. It was headquartered in Boston, MA.	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.	Health Technology